Literature DB >> 34165772

Co-editing PINK1 and DJ-1 Genes Via Adeno-Associated Virus-Delivered CRISPR/Cas9 System in Adult Monkey Brain Elicits Classical Parkinsonian Phenotype.

Hao Li1, Shihao Wu1,2, Xia Ma1,3, Xiao Li2, Tianlin Cheng2, Zhifang Chen2, Jing Wu1, Longbao Lv4, Ling Li5, Liqi Xu6, Wenchao Wang1, Yingzhou Hu1, Haisong Jiang7, Yong Yin8, Zilong Qiu9,10,11, Xintian Hu12,13,14.   

Abstract

Whether direct manipulation of Parkinson's disease (PD) risk genes in the adult monkey brain can elicit a Parkinsonian phenotype remains an unsolved issue. Here, we used an adeno-associated virus serotype 9 (AAV9)-delivered CRISPR/Cas9 system to directly co-edit PINK1 and DJ-1 genes in the substantia nigras (SNs) of two monkey groups: an old group and a middle-aged group. After the operation, the old group exhibited all the classic PD symptoms, including bradykinesia, tremor, and postural instability, accompanied by key pathological hallmarks of PD, such as severe nigral dopaminergic neuron loss (>64%) and evident α-synuclein pathology in the gene-edited SN. In contrast, the phenotype of their middle-aged counterparts, which also showed clear PD symptoms and pathological hallmarks, were less severe. In addition to the higher final total PD scores and more severe pathological changes, the old group were also more susceptible to gene editing by showing a faster process of PD progression. These results suggested that both genetic and aging factors played important roles in the development of PD in the monkeys. Taken together, this system can effectively develop a large number of genetically-edited PD monkeys in a short time (6-10 months), and thus provides a practical transgenic monkey model for future PD studies.

Entities:  

Keywords:  Adeno-associated virus-delivered CRISPR/Cas9; DJ-1; Monkey; PINK1; Parkinsonian phenotype; Parkinson’s disease

Year:  2021        PMID: 34165772     DOI: 10.1007/s12264-021-00732-6

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN: 1995-8218            Impact factor:   5.203


  59 in total

Review 1.  Parkinson's disease.

Authors:  Lorraine V Kalia; Anthony E Lang
Journal:  Lancet       Date:  2015-04-19       Impact factor: 79.321

Review 2.  Neuropathology of Parkinson disease.

Authors:  Dennis W Dickson
Journal:  Parkinsonism Relat Disord       Date:  2017-08-01       Impact factor: 4.891

Review 3.  Genetic animal models of Parkinson's disease.

Authors:  Ted M Dawson; Han Seok Ko; Valina L Dawson
Journal:  Neuron       Date:  2010-06-10       Impact factor: 17.173

Review 4.  Idiopathic Parkinson's disease and the Lewy body disorders.

Authors:  W R Gibb
Journal:  Neuropathol Appl Neurobiol       Date:  1986 May-Jun       Impact factor: 8.090

5.  Nigrostriatal alpha-synucleinopathy induced by viral vector-mediated overexpression of human alpha-synuclein: a new primate model of Parkinson's disease.

Authors:  Deniz Kirik; Lucy E Annett; Corinna Burger; Nicholas Muzyczka; Ronald J Mandel; Anders Björklund
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-24       Impact factor: 11.205

6.  Incidence and pathology of synucleinopathies and tauopathies related to parkinsonism.

Authors:  Rodolfo Savica; Brandon R Grossardt; James H Bower; J Eric Ahlskog; Walter A Rocca
Journal:  JAMA Neurol       Date:  2013-07       Impact factor: 18.302

Review 7.  Why have we failed to achieve neuroprotection in Parkinson's disease?

Authors:  C Warren Olanow; Karl Kieburtz; Anthony H V Schapira
Journal:  Ann Neurol       Date:  2008-12       Impact factor: 10.422

8.  100 years of Lewy pathology.

Authors:  Michel Goedert; Maria Grazia Spillantini; Kelly Del Tredici; Heiko Braak
Journal:  Nat Rev Neurol       Date:  2012-11-27       Impact factor: 42.937

9.  Toxin-induced and genetic animal models of Parkinson's disease.

Authors:  Shin Hisahara; Shun Shimohama
Journal:  Parkinsons Dis       Date:  2010-12-22

10.  A transgenic monkey model for the study of human brain evolution.

Authors:  Lei Shi; Bing Su
Journal:  Zool Res       Date:  2019-04-11
View more
  8 in total

1.  Expanding Views of Mitochondria in Parkinson's Disease: Focusing on PINK1 and GBA1 Mutations.

Authors:  Yu Yuan; Xizhen Ma; Ning Song; Junxia Xie
Journal:  Neurosci Bull       Date:  2022-05-11       Impact factor: 5.271

Review 2.  Application of CRISPR/Cas9 System in Establishing Large Animal Models.

Authors:  Yingqi Lin; Jun Li; Caijuan Li; Zhuchi Tu; Shihua Li; Xiao-Jiang Li; Sen Yan
Journal:  Front Cell Dev Biol       Date:  2022-05-17

Review 3.  CRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson's Disease.

Authors:  Mujeeb Ur Rahman; Muhammad Bilal; Junaid Ali Shah; Ajeet Kaushik; Pierre-Louis Teissedre; Małgorzata Kujawska
Journal:  Pharmaceutics       Date:  2022-06-13       Impact factor: 6.525

4.  PINK1 kinase dysfunction triggers neurodegeneration in the primate brain without impacting mitochondrial homeostasis.

Authors:  Weili Yang; Xiangyu Guo; Zhuchi Tu; Xiusheng Chen; Rui Han; Yanting Liu; Sen Yan; Qi Wang; Zhifu Wang; Xianxian Zhao; Yunpeng Zhang; Xin Xiong; Huiming Yang; Peng Yin; Huida Wan; Xingxing Chen; Jifeng Guo; Xiao-Xin Yan; Lujian Liao; Shihua Li; Xiao-Jiang Li
Journal:  Protein Cell       Date:  2021-11-20       Impact factor: 14.870

Review 5.  Genetically modified large animal models for investigating neurodegenerative diseases.

Authors:  Weili Yang; Xiusheng Chen; Shihua Li; Xiao-Jiang Li
Journal:  Cell Biosci       Date:  2021-12-21       Impact factor: 7.133

Review 6.  Mitochondrial-Dependent and Independent Functions of PINK1.

Authors:  Xiusheng Chen; Qi Wang; Shihua Li; Xiao-Jiang Li; Weili Yang
Journal:  Front Cell Dev Biol       Date:  2022-07-08

Review 7.  Applications of CRISPR-Cas9 in Alzheimer's Disease and Related Disorders.

Authors:  Laura M De Plano; Giovanna Calabrese; Sabrina Conoci; Salvatore P P Guglielmino; Salvatore Oddo; Antonella Caccamo
Journal:  Int J Mol Sci       Date:  2022-08-05       Impact factor: 6.208

Review 8.  New pathogenic insights from large animal models of neurodegenerative diseases.

Authors:  Peng Yin; Shihua Li; Xiao-Jiang Li; Weili Yang
Journal:  Protein Cell       Date:  2022-03-25       Impact factor: 15.328

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.